Coverage
-
May 19, 2017
An Illinois federal jury concluded on Friday that both GlaxoSmithKline and Hospira were injured by the fallout over a troubled contract to manufacture a flu vaccine and awarded both parties damages, giving Hospira a slight edge of $40,000.
2 other articles on this case.
View all »